Guidance

Authors and acknowledgements

Published 21 July 2021

Applies to England

Authors and acknowledgements

Authors

Owen Bowden-Jones, Luke Mitcheson, Laura Pechey, Steve Taylor and Craig Wright.

Acknowledgements

Members of Public Health England’s (PHE) opioid substitution treatment (OST) good practice programme working group, notably representatives from:

  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
  • Lambeth Service User Council
  • Build on Belief and Change Grow Live (Raman Nijhawan)
  • Surrey and Borders Partnership NHS Foundation Trust
  • Turning Point

Background to developing this guide

The OST good practice programme was set up to improve the quality of OST delivery in England. The programme focused on implementing existing clinical guidance through practical and user-friendly tools and resources including:

Organisations involved in PHE’s OST good practice programme

This guidance was developed by PHE and the OST good practice programme working group, which included representatives from the following organisations:

  • Avon and Wiltshire Mental Health Partnership NHS Trust
  • Birmingham and Solihull Mental Health NHS Foundation Trust
  • Build on Belief
  • Central and North West London NHS Foundation Trust
  • Change Grow Live
  • Collective Voice
  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
  • Dorset County Council
  • EDP Drug and Alcohol Services
  • Essex County Council
  • Foundations
  • Inclusion Recovery Hampshire
  • Lambeth Service User Involvement Council
  • Midlands Partnership Foundation Trust
  • NHS Addictions Providers Alliance
  • South London and Maudsley NHS Foundation Trust
  • Surrey and Borders Partnership NHS Foundation Trust
  • Turning Point
  • We Are With You (formerly Addaction)

Disclaimer

This guide has been developed to assist and support drug treatment and recovery workers in developing good practice. It does not override or replace national and clinical guidelines in any circumstances. Drug misuse and dependence: UK guidelines on clinical management (also known as the ‘orange book’) remains the authoritative national guidance on drug treatment.